Breast cancer is the first or second leading cancer among females across the globe. A large number of studies have been conducted to assess any relationship between vitamin D receptor (VDR) gene polymorphisms and breast cancer development. Epidemiological studies have indicated that ethnic traits exhibited by a group of people with a common ancestry and culture, alter the link between VDR gene and breast cancer. It has been hypothesized that VDR polymorphisms have the capacity to impact both on incidence of breast cancer occurrence and to predict its outcome. A survey was here conducted to assess and compare the impact of vitamin D receptor gene polymorphisms Fok1, Bsm1, Taq1, Apa1 and poly (A) on development of breast cancer. Information was obtained from electronic databases including PubMed and Google Scholar for articles published during the period from 1996 to 2015. This search was achieved by using the terms "genetics", "breast cancer", "VDR gene", "polymorphisms". However, due to inconsistent results, no conclusive statements could be presented about the significance of the VDR genotype as far as the development of breast carcinoma is concerned'
Introduction
Breast cancer stands the second most leading cancer among females around the globe (Du et al., 2014) . It is the most frequently diagnosed cancer in Pakistan, with highest mortality rate in Asian population after the Jews from Israel. Karachi, has the maximum rate of breast carcinoma (38%) in female among the registered cancer cases (Iqbal MuN, 2015) . The incidence rate of carcinoma of breast is comparable with highest risk regions in the world (Bhurgri et al., 2006) . The overall risk of developing carcinoma of breast makes it the most frequent malignancy among the white females with estimates of 1 in 12 British and 1 in 8 American women (Khan et al., 2014) .
The risk of breast cancer has been evaluated in relation to vitamin D receptor gene polymorphisms in number of studies because of evidence of regulatory effects on angiogenesis in malignancy (Banerjee, 2003; Giovannucci, 2005) . The VDR was discovered in 1969 (Norman, 2008) . Discovery of VDR expression in diverse normal human tissues cells has widened the perceived scope of the vitamin D. Vitamin D endocrine system is involved in several processes besides bone formation, like innate immunity, apoptosis, cell proliferation and differentiation, and mediates the anticancer activities of vitamin D via the Vitamin D Receptor (VDR) (Raimondi et al., 2009) .
Female breast cancer occurrence is strongly age related, suggesting a link with hormonal status. Contrary to international studies, Pakistani women between 20 to 35 years of age are frequently reported in Karachi hospitals
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Fouzia Shaikh*, Saeeda Baig, Qamar Jamal with advanced stages of breast cancer with large lesions, and are prone to develop metastasis with bad prognosis (Bhurgri et al., 2006; Naveed et al., 2014) . In the UK between the years 2009 and 2011, approximately 80% of breast cancer cases were diagnosed above the age of 50 years, and about 24% in women aged 75 years and above, based on Breast cancer incidence statistics (2013).
The objectives of this search were to determine the effect of polymorphisms of the frequent SNPs in VDR (Fok1, Bsm1, Taq1, Apa1, Poly A) and the evolution of the breast carcinoma.
Discussion
Breast carcinoma is the cumulative result of various environmental and genetic alterations. Mechanism of breast cancer development is still not well established, but published data has identified the anti-cancerous functions of 1, 25 (OH)2 vitamin D3 in some malignancies (Iqbal MuN, 2015) .
VDR Receptors in Mammary Glands: The calcitriol receptor also known as vitamin D receptor (VDR) is an intracellular hormone receptor, and a member of the nuclear class II receptor family of broadly known two groups and peculiarly binds to biologically effective form of vitamin D, 1,25-dihydroxyvitamin D (Raimondi et al., 2009) . One family comprises of the estrogen, androgen, progesterone and mineralocorticoid receptors, while the other has thyroid (THR), vitamin D (VDR), retinoic acid (RAR), peroxisome proliferator-activated, and retinoid X receptors (RXR) (Ditsch et al., 2012) . More than 36 types of tissue in the body have expression of Vitamin D Receptor like breast, bone, prostate, gut, activated B and T lymphocytes, monocytes, and keratinocytes with distinct mitochondrial, membrane, cytosol and perinuclear localization (Gombart, 2006; Silvagno et al., 2010) . In normal mammary gland VDR is expressed in epithelial, stromal, and immune cells and is controlled in the epithelial compartment during hormonal changes during puberty and pregnancy (Zinser, 2004) . Figure1 Several studies show that genetic variance can affect an individual receptivity to dietary or pharmacological interventions (Welsh, 2007) . SNPs are widely dispersed through the human genome and because of great levels of inconsistency, have gained reputation as genetic markers helpful in attaining disease vulnerability in complicated genetic characteristics (Collins et al., 1997) .
VDR Gene and Breast Cancer: The molecular location of VDR receptor gene is on the long arm of chromosome 12 (12q12-q14) and includes not less than 11 exons that stretch 60 kb of DNA with five promoter regions (Zhou, 2009) . Figure 2 VDR Genotypes and Polymorphisms: VDR gene has more than 470 single-nucleotide polymorphisms (SNPs) (Zmuda et al., 2000; Mc Cullough et al., 2009) . The important and intensively studied single nucleotide polymorphisms (SNPs) of VDR are, FokI (rs2228570), VDR-BsmI (rs1544410), VDR-TaqI (rs731236), VDRApaI (rs7975232) and Poly(A) (Alimirah et al., 2011) . Over the years, most of The molecular epidemiological studies have been done to relate the associations of important VDR polymorphisms with breast cancer (Curran et al., 1999; Ingles et al., 2000; Bretherton et al., 2001; Hou et al., 2002; Buyru et al., 2003; Guy et al., 2004; Sillanpaa et al., 2004; Chen et al., 2005; Lowe et al., 2005; John et al., 2007; Mc Cullough et al., 2007; Trabert et al., 2007; Abbas et al., 2008; Barroso et al., 2008; Sinotte et al., 2008; Chakraborty et al., 2009; McKay et al., 2009; Rollison et al., 2011; Huang et al., 2012; Mishra et al., 2013; Du et al., 2014 Ethnic Variation in VDR Gene Polymorphisms: VDR gene show sequence level dissimilarity in the different populations, both at the 5' and 3' termini (Trabert et al., 2007) . Epidemiological studies have frequently reported that the fundamental features of the population with varying ethnicities can alter the links between VDR gene polymorphisms and carcinoma. The ethnic groups were categorized into (Caucasian, Asian, and AfricanAmerican) by Wang et al., 2013 . Review by Uitterlinden AG et al. (2004) and Kostner et al. (2009) showing ethnic variation. Indian subcontinent where populations/ethnicity are quite different, not much information regarding the allelic variations of VDR (Fok1) gene is available (Bid, 2003) . Figure 3 The VDR gene FokI polymorphism and breast cancer risk: The Fork1 restriction enzyme occupies a polymorphic site in exon 2 of the VDR gene (Yang B et al., 2014) . Genotypes are identified as FF, Ff and ff for the VDR-FokI polymorphisms. The capital letter indicates the absence and small letter the existence of the restriction site (Uitterlinden et al., 2004) . The alliance of Fok1 polymorphism with breast cancer reveals that Fok1 is the most controversial SNP. VDR FF allele in combination with long-Poly A was reported to be a possible risk factor in the UK in the study by Guy et al. (2004) , whereas Chen et al (2005) found VDR ff to be a risk factor in the Nurses' Health study in the USA. In the year 2009, the meta-analysis was done by Tang et al, which shows a strong connection between VDR ff and raised risk of breast cancer in European females. Study by Shahbazi et al. (2013) on Iranian breast cancer patients could not establish statistically significant affiliation between Fok1 genotypes and breast carcinoma. However in 2013, Mishra et al, proposed that VDR FokI f allele may share in the evolution of breast carcinoma in young age and F allele in tumor progression and patient prognosis.
The VDR gene BsmI polymorphism and breast cancer risk: The Bsm1 polymorphism is situated at the 3' end of the VDR gene. It does not affect the quality of the translated VDR protein (Raimondi Set al., 2009) . Genotypes assigned are BB, Bb, bb for the BsmI polymorphisms. The second most frequent studied VDR polymorphism-BsmI, which after analysis showed mixed results. Some studies reported its association with breast cancer development (Guy et al., 2004; Shahbazi et al., 2013) .The study by Lowe et al. (2005) shows strong association between the VDR bb genotype and breast cancer. Studies by other researchers did not reveal any significant difference in the prevalence of the BsmI polymorphism in breast cancer patients (Chen et al., 2005 ; DOI:http://dx.doi.org/10.7314/APJCP.2016 .17.2.479 Do VDR Gene Polymorphisms Contribute to Breast Cancer? Wang et al., 2013 Zhang, 2014) .
The VDR gene ApaI polymorphism and breast cancer risk: Apa1 restriction sites lies in an intronic region between exon VII and IX (Buyru N et al., 2003) . Genotypes were designated as AA, Aa, aa for the ApaI polymorphisms. VDR Apa1polymorphisms were identified to have significant association with tumor differentiation. Anaplastic tumors are more inclined to express a polymorphic allele of VDR ApaI (Aa or aa). Alleles of VDR, ApaI confer an increased risk for breast cancer development in few studies (Guy et al., 2004; Engel et al., 2013; Fuhrman et al., 2013) ,but data from various other researches showed no associations between the VDR variants ApaI and breast cancer (Hou et al., 2002; Bhanushali et al., 2009; Chakraborty et al., 2009; Dalessandri et al., 2011; Mishra et ai., 2013) .
VDR gene TaqI po lymorphism and breast cancer risk: The TaqI polymorphism is a T/C nucleotide substitution (ATT to ATC), an RFLP at codon 352 in exon 9 of the VDR gene. Individuals are generally designated as TT, Tt or tt. Taq1 shows a definite association with breast cancer in few researches. Study by Perna L et al (2013) , points to a significant prognostic value of taq1in breast cancer patients. No significant increase in risk for breast cancer has been seen in women both heterozygous and homozygous for t allele in multiple studies (Wang et al., 2013) .
The VDR gene poly(A) polymorphism and breast cancer risk: The poly (A) mononucleotide repeat occupies the 3'-untranslated region (3'-UTR) section of the gene, firmly interconnected with Bsm1, Apa1 and Taq1 has a strong influence on VDR mRNA integrity (Gombart, 2006) . Individuals are categorized as having alleles with short (S, with <18 As) or long (L, with >18 As) poly (A) stretches. The S allele is considered to be the more effective VDR allele (Mishra et al., 2013) .
Vitamin D receptor (VDR) poly (A), polymorphism has been implicated in the development of breast 
Conclusion
Insight into the role of VDR polymorphisms imparts idealistic vision or perception which can expedite the development of up to date prophylactic approaches for breast malignancies.
The evaluation of data regarding the VDR gene polymorphisms, most prevalent in breast carcinoma of various ethnic populations shows diverse results. This might be due to the limitation of individual studies or genetic variations due to racial or cultural diversity.
